References
- Bennett W M, Elzinga L W, Porter GA. Tubulointerstitial disease and toxic nephropathy. The Kidney4th ed., BM Brenner, FC Rector, Jr. WB Saunders Company, Philadelphia 1991; vol 2: 1430–1496
- Bianchi C, Donadio C, Tramonti G. Noninvasive methods for the measurement of total renal function. Nephron 1981; 28: 53–57
- Persijn J P, Van Der Slik W. A new method for the determination of γ-glutamyltransferase in serum. J Clin Chem Clin Biochem 1976; 14: 421–427
- Recommendations of the German Society for Clinical Chemistry. Standardization of methods for the estimation of enzyme activities in biological fluids. Experimental basis for the optimized standard conditions. Z Klin Chem Klin Biochem 1972; 10: 281–291
- Stark J J, Howell SB. Nephrotoxicity of cis-platinum (II) dichlorodiammine. Clin Pharmacol Ther 1978; 23: 461–466
- Ozols R F, Corden B J, Jacob J, Wesley M N, Ostchega Y, Young RC. High-dose cisplatin in hypertonic saline. Ann Intern Med 1984; 10: 19–24
- Salem P, Khalyl M, Jabboury K, Hashimi L. Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new schedule with minimal toxicity. Cancer 1984; 53: 837–840
- Jones B R, Bhalla R B, Mladek J, Kaleya R N, Gralla R J, Alcock N W, Schwartz M K, Young C W, Reidenberg MM. Comparison of methods of evaluating nephrotoxicity of cis-platinum. Clin Pharmacol Ther 1980; 27: 557–562
- Verplanke A JW, Herber R FM, De Wit R, Veenhof C HN. Comparison of renal function parameters in the assessment of cis-platin induced nephrotoxicity. Nephron 1994; 66: 267–272